| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 20 securities · passive | ||||||
|
Traws Pharma, Inc.
13G
TRAW · 68232V884
|
9.9% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 9.9% | |||||
| Alex Silverstein | 9.9% | |||||
|
Tonix Pharmaceuticals Holding Corp.
13G/A
TNXP · 890260839
|
4.9% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 4.9% | |||||
| Alex Silverstein | 4.9% | |||||
|
Q32 Bio Inc.
13G/A
QTTB · 746964105
|
0% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 0% | |||||
| Alex Silverstein | 0% | |||||
|
InflaRx N.V.
13G
IFRX · N44821101
|
6.1% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 6.1% | |||||
| Alex Silverstein | 6.1% | |||||
|
Immunome Inc.
13G/A
IMNM · 45257U108
|
4.3% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 4.3% | |||||
| Alex Silverstein | 4.3% | |||||
|
First Tracks Biotherapeutics, Inc.
13G
TRAX · 337185102
|
7.2% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 7.2% | |||||
| Alex Silverstein | 7.2% | |||||
|
Dianthus Therapeutics, Inc. /DE/
13G/A
DNTH · 252828108
|
3.1% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 3.1% | |||||
| Alex Silverstein | 3.1% | |||||
|
Design Therapeutics, Inc.
13G
DSGN · 25056L103
|
9.5% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 9.5% | |||||
| Alex Silverstein | 9.5% | |||||
|
Cybin Inc.
13G/A
HELP · 23256X407
|
4.8% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 4.8% | |||||
| Alex Silverstein | 4.8% | |||||
|
AnaptysBio, Inc.
13G/A
ANAB · 032724106
|
5.0% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 5.0% | |||||
| Alex Silverstein | 5.0% | |||||
|
Alto Neuroscience, Inc.
13G/A
ANRO · 02157Q109
|
6.2% |
8/14/2026
Event 6/30/2026
|
||||
| Sirenia Capital Management LP | 6.2% | |||||
| Alex Silverstein | 6.2% | |||||
|
iBio, Inc.
13G
IBIO · 451033708
|
9.9% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 9.9% | |||||
| Alex Silverstein | 9.9% | |||||
|
Edesa Biotech, Inc.
13G
EDSA · 27966L306
|
7.2% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 7.2% | |||||
| Alex Silverstein | 7.2% | |||||
|
Corvus Pharmaceuticals, Inc.
13G
CRVS · 221015100
|
7.5% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 7.5% | |||||
| Alex Silverstein | 7.5% | |||||
|
C4 Therapeutics, Inc.
13G
CCCC · 12529R107
|
9.9% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 9.9% | |||||
| Alex Silverstein | 9.9% | |||||
|
Xilio Therapeutics, Inc.
13G
XLO · 98422T100
|
9.9% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 9.9% | |||||
| Alex Silverstein | 9.9% | |||||
|
Palatin Technologies Inc
13G
PTN · 696077601
|
9.9% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 9.9% | |||||
| Alex Silverstein | 9.9% | |||||
|
Ovid Therapeutics Inc.
13G
OVID · 690469101
|
9.9% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 9.9% | |||||
| Alex Silverstein | 9.9% | |||||
|
OKYO Pharma Ltd
13G
OKYO · G6724L116
|
7.7% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 7.7% | |||||
| Alex Silverstein | 7.7% | |||||
|
Kodiak Sciences Inc.
13G
KOD · 50015M109
|
5.7% |
5/15/2026
Event 3/31/2026
|
||||
| Sirenia Capital Management LP | 5.7% | |||||
| Alex Silverstein | 5.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.